Factors associated with the early resumption of sexual activity following medical male circumcision in nyanza province, Kenya

AIDS and Behavior

Volumn 16, Issue 5, 2012, Pages 1173-1181

  Herman Roloff, Amy ^a,b   Bailey, Robert C ^a,b   Agot, Kawango ^c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b NYANZA REPRODUCTIVE HEALTH SOCIETY   (Kenya)

^c IMPACT RESEARCH AND DEVELOPMENT ORGANIZATION   (Kenya)

Author keywords

HIV; Kenya; Sexual intercourse; Voluntary medical male circumcision; Wound healing

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; CIRCUMCISION; CLINICAL TRIAL; COITUS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUNSELING; FOLLOW UP; HUMAN; KENYA; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATIENT EDUCATION; PHYSICAL EXAMINATION; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; STATISTICS; TEXT MESSAGING; TIME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; CIRCUMCISION, MALE; COITUS; COUNSELING; FOLLOW-UP STUDIES; HUMANS; KENYA; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PHYSICAL EXAMINATION; PROSPECTIVE STUDIES; TEXT MESSAGING; TIME FACTORS; YOUNG ADULT;

EID: 84863726816     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-011-0073-1     Document Type: Article

References (17)

1. UNAIDS. Voluntary medical male circumcision: global trends and determinants of prevalence, safety, and acceptability. Geneva: World Health Organization; 2007.
2. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of voluntary medical male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med. 2005;2(11):e298.
3. Bailey RC, Moses S, Parker CB, et al. Voluntary medical male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomized controlled trial. Lancet. 2007;369(9562): 643-56. (Pubitemid 46281312)
4. Gray RH, Kigozi G, Serwadda D, et al. Voluntary medical male circumcision for HIV prevention in men in Rakai, Uganda: a randomized trial. Lancet. 2007;369(9562):657-66.
5. Weiss HA, Halperin D, Bailey RC, Hayes RJ, Schmid G, Hankins CA. Voluntary medical male circumcision for HIV prevention: from evidence to action? AIDS. 2008;22:567-74. (Pubitemid 351640589)
6. World Health Organization. New data on voluntary medical male circumcision and HIV prevention: policy and programme implications. 2007. http://data.unaids.org/pub/Report/2007/VMMC-recommendations-en.pdf. Accessed 24 March 2011.
7. UNAIDS/WHO/SACEMA Expert Group on Modelling the Impact and Cost of Voluntary Medical Male Circumcision for HIV Prevention. Voluntary medical male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making? PLoS Med. 2009;6(9):e1000109. doi:10.1371/journal.pmed.1000109.
8. de Bruyn G, Martinson NA, Gray GE. Voluntary medical male circumcision for HIV prevention: developments from Sub-Saharan Africa. Expert Rev Anti Infect Ther. 2010;8(1):23-31.
9. Weiss H, Hankins C, Dickson K. Voluntary medical male circumcision and risk of HIV infection in women: a systematic review and meta-analysis. Lancet Infect Dis. 2009;9:669-77.
10. Mehta SD, Gray RH, Auvert B, et al. Does sex in the early period after circumcision increase HIV-seroconversion risk? Pooled analysis of adult voluntary medical male circumcision clinical trials. AIDS. 2009;23(12):1557-64.
11. Wawer MJ, Makumbi F, Kigozi G, et al. Circumcision in HIVinfected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial. Lancet. 2009;374(9685):229-37.
12. Kenya National Bureau of Statistics and ICF Macro. Kenya Demographic and Health Survey 2008-09. Calverton: KNBS and ICF Macro. 2010.
13. National AIDS and STI Control Programme, Ministry of Health, Kenya. Guidelines for Safe, Voluntary Medical Voluntary medical male circumcision in Kenya. 2008.
14. Brachman PS. Surveillance and the primary care physician. J Postgrad Med. 1977;62(2):86-91. (Pubitemid 8140350)
15. Vogt RL, LaRue D, Klaucke DN, Jillson DA. Comparison of an Active and passive surveillance system of primary care providers for hepatitis, measles, rubella, and salmonellosis in vermont. Am J Public Health. 1983;73(7):795-7. (Pubitemid 13059142)
16. Wood JL, Adams VJ. Epidemiological approaches to safety investigations. Vet Microbiol. 2006;117(1):66-70. (Pubitemid 44354901)
17. Lissouba P, Taljaard D, Rech D, et al. A model for the roll-out of comprehensive adult voluntary medical male circumcision services in African low-income settings of high HIV incidence: the ANRS 12126 bophelo pele project. PLoS Med. 2010;7(7):e100 0309. doi:10.1371/journal.pmed.1000309.